January 29, 2008
Tranzyme Receives IND Clearance for TZP-102
December 19, 2007
Tranzyme to Present at the 26th Annual JPMorgan Healthcare Conference
November 01, 2007
Tranzyme Pharma Closes New $20 Million Financing
TZP-101 selected by Thomson Pharma as one of the five most promising Phase I drugs. Click here to read more.